QuidelOrtho

QDELNasdaq United States Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$837.726 M

$12.29 -24.72%

Close of 7 Aug 2026

Revenue

$2.73B

#980 by revenue

Earnings

-$1.13B

Loss-making

Shares outstanding

68,575,427

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances — ranked by market cap

All 19 →

#6Intellia TherapeuticsNTLA$1.67B
#7Anbio BiotechnologyNNNN$1.53B
#8QuidelOrthoQDEL$837.7M
#9Achieve Life SciencesACHV$682.7M
#10Alpha TeknovaTKNO$346.3M

Where these numbers come from

Share counts and financials for QuidelOrtho are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.